We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VANI icon
4026
Vivani Medical
VANI
$110M
$28K ﹤0.01%
9,813
GRCE
4027
Grace Therapeutics
GRCE
$33.8M
$28K ﹤0.01%
1,276
OIIM
4028
DELISTED
02Micro International
OIIM
$27K ﹤0.01%
16,202
APEX
4029
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$26K ﹤0.01%
2,388
TAT
4030
DELISTED
TransAtlantic Petroleum LTD.
TAT
$26K ﹤0.01%
97,946
STAF
4031
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$25K ﹤0.01%
54
MDLY
4032
DELISTED
Medley Management Inc
MDLY
$25K ﹤0.01%
3,271
FWDI
4033
Forward Industries Inc
FWDI
$297M
$24K ﹤0.01%
1,882
DCOY
4034
Decoy Therapeutics
DCOY
$2.19M
$24K ﹤0.01%
1
XPL icon
4035
Solitario Resources
XPL
$68.3M
$23K ﹤0.01%
75,942
ALJJ
4036
DELISTED
ALJ Regional Holdings Inc
ALJJ
$23K ﹤0.01%
47,893
+20,003
+72% +$10.8K
GLEO.WS
4037
DELISTED
Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
GLEO.WS
$23K ﹤0.01%
51,001
-403,821
-89% -$111K
BCOM
4038
DELISTED
B Communications Ltd
BCOM
$23K ﹤0.01%
11,674
SONM icon
4039
DNA X Inc
SONM
$5.05M
$22K ﹤0.01%
15
-30
-67% -$47.9K
BIOL
4040
DELISTED
Biolase, Inc.
BIOL
$22K ﹤0.01%
19
MARA icon
4041
Marathon Digital Holdings
MARA
$4.32B
$21K ﹤0.01%
23,566
DTEA
4042
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$21K ﹤0.01%
21,923
JG
4043
Aurora Mobile
JG
$33.4M
$20K ﹤0.01%
630
+101
+19% +$3.97K
TONX
4044
TON Strategy Co
TONX
$168M
$20K ﹤0.01%
2
LFWD icon
4045
ReWalk Robotics
LFWD
$20.3M
$20K ﹤0.01%
135
PACK.WS
4046
DELISTED
One Madison Corporation Warrants, each whole warrant is exercisable for one Class A Common Stock at
PACK.WS
$20K ﹤0.01%
21,500
NCTY
4047
The9 Ltd
NCTY
$68.1M
$19K ﹤0.01%
238
CSCI
4048
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$19K ﹤0.01%
239
ATCXW
4049
DELISTED
Atlas Technical Consultants, Inc. Warrant
ATCXW
$19K ﹤0.01%
48,800
-875,412
-95% -$490K
AGIG
4050
Abundia Global Impact Group
AGIG
$42.5M
$18K ﹤0.01%
1,082

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.